Carisma Therapeutics
CARM
CARM
56 hedge funds and large institutions have $37.3M invested in Carisma Therapeutics in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 3 closing their positions.
Holders
56
Holders Change
+11
Holders Change %
+24.44%
% of All Funds
0.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
16
Reduced
11
Closed
3
Calls
$80K
Puts
$174K
Net Calls
-$94K
Net Calls Change
-$689K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$7.96M |
| 2 |
2
Renaissance Technologies
New York
|
$3.93M |
| 3 |
3
Millennium Management
New York
|
$860K |
| 4 |
4
Two Sigma Advisers
New York
|
$971K |
| 5 |
5
Morgan Stanley
New York
|
$2.35M |
Top Sellers
| 1 |
1
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$446K |
| 2 |
2
Squarepoint
New York
|
$0 |
| 3 |
3
Goldman Sachs
New York
|
$45K |
| 4 |
4
Jane Street
New York
|
$53K |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$83K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PA
51
Parallel Advisors
San Francisco,
California
| $6K | -$586 | -21 | -9% |
|
|
KC
52
Kinloch Capital
Glen Allen,
Virginia
| $3K | +$3K | +100 | New |
|
53
UBS Group
Zurich,
Switzerland
| $2K | – | – | – |
|
|
RFA
54
Reilly Financial Advisors
La Mesa,
California
| $2K | +$750 | +33 | +60% |
|
55
Citigroup
New York
| $1K | – | – | – |
|
|
OSAM
56
O'Shaughnessy Asset Management
Stamford,
Connecticut
| $1K | +$1K | +40 | New |
|
|
57
Squarepoint
New York
| – | -$274K | -9,770 | Closed |
|
|
TSS
58
Two Sigma Securities
New York
| – | -$29K | -1,021 | Closed |
|
59
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -68 | Closed |
|